Literature DB >> 31905237

Can my computer tell me if this tumor is IDH mutated?

Timothy J Kaufmann1, Bradley J Erickson1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31905237      PMCID： PMC7058444          DOI： 10.1093/neuonc/noaa002

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

Review 1.  Deep learning can see the unseeable: predicting molecular markers from MRI of brain gliomas.

Authors:  P Korfiatis; B Erickson
Journal:  Clin Radiol       Date:  2019-03-05       Impact factor: 2.350

2.  What Does Deep Learning See? Insights From a Classifier Trained to Predict Contrast Enhancement Phase From CT Images.

Authors:  Kenneth A Philbrick; Kotaro Yoshida; Dai Inoue; Zeynettin Akkus; Timothy L Kline; Alexander D Weston; Panagiotis Korfiatis; Naoki Takahashi; Bradley J Erickson
Journal:  AJR Am J Roentgenol       Date:  2018-11-07       Impact factor: 3.959

3.  A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.

Authors:  Chandan Ganesh Bangalore Yogananda; Bhavya R Shah; Maryam Vejdani-Jahromi; Sahil S Nalawade; Gowtham K Murugesan; Frank F Yu; Marco C Pinho; Benjamin C Wagner; Bruce Mickey; Toral R Patel; Baowei Fei; Ananth J Madhuranthakam; Joseph A Maldjian
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Prerana Jha; Pankaj Pathak; Vaishali Suri; Chitra Sarkar; Kunzang Chosdol; Ashish Suri; Shashank Sharad Kale; Ashok Kumar Mahapatra; Pankaj Jha
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

Review 5.  State of the Art: Machine Learning Applications in Glioma Imaging.

Authors:  Eyal Lotan; Rajan Jain; Narges Razavian; Girish M Fatterpekar; Yvonne W Lui
Journal:  AJR Am J Roentgenol       Date:  2018-10-17       Impact factor: 3.959

6.  IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Authors:  Jason Beiko; Dima Suki; Kenneth R Hess; Benjamin D Fox; Vincent Cheung; Matthew Cabral; Nicole Shonka; Mark R Gilbert; Raymond Sawaya; Sujit S Prabhu; Jeffrey Weinberg; Frederick F Lang; Kenneth D Aldape; Erik P Sulman; Ganesh Rao; Ian E McCutcheon; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

7.  Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas.

Authors:  Jane B Cryan; Sam Haidar; Lori A Ramkissoon; Wenya Linda Bi; David S Knoff; Nikolaus Schultz; Malak Abedalthagafi; Loreal Brown; Patrick Y Wen; David A Reardon; Ian F Dunn; Rebecca D Folkerth; Sandro Santagata; Neal I Lindeman; Azra H Ligon; Rameen Beroukhim; Jason L Hornick; Brian M Alexander; Keith L Ligon; Shakti H Ramkissoon
Journal:  Oncotarget       Date:  2014-09-30

8.  Estimating genotype error rates from high-coverage next-generation sequence data.

Authors:  Jeffrey D Wall; Ling Fung Tang; Brandon Zerbe; Mark N Kvale; Pui-Yan Kwok; Catherine Schaefer; Neil Risch
Journal:  Genome Res       Date:  2014-10-10       Impact factor: 9.043

Review 9.  Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging.

Authors:  Madeleine M Shaver; Paul A Kohanteb; Catherine Chiou; Michelle D Bardis; Chanon Chantaduly; Daniela Bota; Christopher G Filippi; Brent Weinberg; Jack Grinband; Daniel S Chow; Peter D Chang
Journal:  Cancers (Basel)       Date:  2019-06-14       Impact factor: 6.639

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.